Codon Genomics is involved in sequencing and bioinformatics, specifically in agrigenomics, pathogen research, and fundamental sciences. They also provide data collection and software solutions along with consultation and training services.

Codon Genomics

Illuminas provides research solutions in various industries including technology, financial services, and healthcare. Self-described capabilities include quantitative and qualitative research, advanced analytics, and data visualization.

Illuminas

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Metric
Company Name	Codon Genomics	Illuminas	Thermo Fisher Scientific Inc.
Symbol			TMO
MSH ID	COM:CODONGENOMICS	COM:ILLUMINAS	COM:THERMOFISHER
Market	PRIVATE	PRIVATE	STOCKS
Sector	Healthcare & Health Services	Commercial & Professional Services	Healthcare
Industry	Biotechnology	Market Research	Medical - Diagnostics & Research
Country	US	UK	US
Stage
Employee Count			122K
Website	codongenomics.com	illuminas.com	thermofisher.com
LinkedIn
Founders

Metric
Market Cap			204.93B
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue			42.86B
Revenue (LTM)
Revenue (NTM)
Gross Profit			17.56B
EBITDA			6.86B
Operating Income			6.86B
Net Income			6.00B
EPS			15.53
Diluted EPS			15.45
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin			0.42
Operating Profit Margin			0.17
EBITDA Margin			0.16
Net Profit Margin			0.15
Return on Equity			0.13
Return on Assets			0.06
Return on Capital Employed			0.09

COM:CODONGENOMICS

Codon Genomics

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio			35.85
P/B Ratio			4.70
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio			5.61
EV Multiple			20.87

Metric
Days Sales Outstanding			70.36
Days Payables Outstanding			35.73
Days Inventory Outstanding			76.60
Operating Cycle			157.60
Cash Conversion Cycle			145.06
Asset Turnover			0.44

Metric
Operating Cash Flow			8.41B
Free Cash Flow			6.93B
Cash Flow to Debt			0.26
Operating Cash Flow/Sales			0.22
Free Cash Flow Yield			0.03

Metric
Cash & Equivalents			8.08B
Accounts Receivable			-43M
Inventory			5.09B
Goodwill			44.02B
Debt to Capitalization			0.44
Debt to Assets			0.36
Current Ratio			1.63
Quick Ratio			1.37

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue			-0.00
R&D to Revenue			0.03
SG&A to Revenue